Citatuzumab bogatox

Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, a ribosome inactivating protein from the plant Bougainvillea spectabilis.[1] It has undergone preclinical development for the treatment of ovarian cancer and other solid tumors.[2]

Citatuzumab bogatox
Monoclonal antibody
TypeFab fragment
SourceHumanized (from mouse)
TargetTACSTD1
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC3455H5371N921O1060S18
Molar mass77348.44 g·mol−1
 NY (what is this?)  (verify)

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.